Total Payments
$26,848
2024 Payments
$3,651
Companies
29
Transactions
138
Medicare Patients
883
Medicare Billing
$87,069
Payment Breakdown by Category
Other$10,638 (39.6%)
Consulting$9,952 (37.1%)
Food & Beverage$4,913 (18.3%)
Travel$1,276 (4.8%)
Education$68.99 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,638 | 5 | 39.6% |
| Consulting Fee | $9,952 | 5 | 37.1% |
| Food and Beverage | $4,913 | 123 | 18.3% |
| Travel and Lodging | $1,276 | 4 | 4.8% |
| Education | $68.99 | 1 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $12,230 | 28 | $0 (2024) |
| Bayer HealthCare Pharmaceuticals Inc. | $4,000 | 1 | $0 (2022) |
| Medtronic Vascular, Inc. | $3,551 | 11 | $0 (2019) |
| Edwards Lifesciences Corporation | $1,787 | 10 | $0 (2022) |
| Philips Electronics North America Corporation | $1,552 | 1 | $0 (2018) |
| Boston Scientific Corporation | $762.56 | 13 | $0 (2024) |
| Abbott Laboratories | $563.49 | 13 | $0 (2024) |
| Medicure Pharma Inc. | $500.00 | 1 | $0 (2018) |
| ABIOMED | $455.35 | 14 | $0 (2024) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $353.13 | 12 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,651 | 29 | E.R. Squibb & Sons, L.L.C. ($2,890) |
| 2023 | $10,108 | 38 | E.R. Squibb & Sons, L.L.C. ($9,261) |
| 2022 | $4,408 | 5 | Bayer HealthCare Pharmaceuticals Inc. ($4,000) |
| 2021 | $164.17 | 8 | Medtronic, Inc. ($61.24) |
| 2020 | $150.66 | 9 | ABIOMED ($119.55) |
| 2019 | $2,137 | 19 | Edwards Lifesciences Corporation ($1,724) |
| 2018 | $5,678 | 16 | Medtronic Vascular, Inc. ($3,413) |
| 2017 | $551.52 | 14 | Abbott Laboratories ($283.63) |
All Payment Transactions
138 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $10.92 | General |
| Category: Cardiovascular | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.82 | General |
| Category: Cardiovascular | ||||||
| 11/13/2024 | Chiesi USA, Inc. | KENGREAL (Drug) | Food and Beverage | Cash or cash equivalent | $15.48 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/06/2024 | E.R. Squibb & Sons, L.L.C. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,604.00 | General |
| 10/24/2024 | E.R. Squibb & Sons, L.L.C. | — | Food and Beverage | Cash or cash equivalent | $108.52 | General |
| 10/23/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $99.79 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/02/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $73.49 | General |
| Category: AVVIGO_IC | ||||||
| 09/30/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $7.01 | General |
| Category: Cardiovascular | ||||||
| 09/20/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $84.84 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/17/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $88.42 | General |
| Category: AVVIGO_IC | ||||||
| 09/17/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $52.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/16/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.49 | General |
| Category: Cardiovascular | ||||||
| 08/21/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $110.88 | General |
| Category: Cardiovascular | ||||||
| 08/21/2024 | Kestra Medical Technology Services, Inc. | Assure WCD (Device) | Food and Beverage | Cash or cash equivalent | $22.04 | General |
| Category: Cardiology | ||||||
| 08/19/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $14.60 | General |
| Category: Not Applicable | ||||||
| 07/31/2024 | Boston Scientific Corporation | AVVIGO Guidance System (Device) | Food and Beverage | In-kind items and services | $54.67 | General |
| Category: AVVIGO_IC | ||||||
| 07/16/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $7.39 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/03/2024 | Abbott Laboratories | DIAMONDBACK CORONARY (Device) | Food and Beverage | In-kind items and services | $26.19 | General |
| Category: Vascular | ||||||
| 05/30/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Not Applicable | ||||||
| 05/30/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $4.96 | General |
| Category: Cardiovascular | ||||||
| 05/07/2024 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $6.74 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/17/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: Vascular | ||||||
| 04/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $23.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/01/2024 | Abbott Laboratories | DIAMONDBACK CORONARY (Device) | Food and Beverage | In-kind items and services | $33.62 | General |
| Category: Vascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 585 | 628 | $172,138 | $49,727 |
| 2021 | 6 | 171 | 187 | $45,328 | $19,585 |
| 2020 | 6 | 127 | 138 | $46,448 | $17,757 |
Total Patients
883
Total Services
953
Medicare Billing
$87,069
Procedure Codes
24
All Medicare Procedures & Services
24 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92928 | Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | Facility | 2023 | 30 | 33 | $46,200 | $13,050 | 28.2% |
| 93458 | Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | Facility | 2023 | 66 | 66 | $38,486 | $11,951 | 31.1% |
| 93454 | Insertion of tube in coronary artery for diagnosis with review by radiologist | Facility | 2023 | 48 | 48 | $22,368 | $6,637 | 29.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 38 | 44 | $14,960 | $5,615 | 37.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 22 | 22 | $9,834 | $3,408 | 34.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 29 | 29 | $10,440 | $2,947 | 28.2% |
| 99152 | Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | Facility | 2023 | 136 | 144 | $14,384 | $1,293 | 9.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 12 | $3,000 | $1,136 | 37.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 157 | 183 | $3,294 | $1,092 | 33.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 20 | 20 | $2,760 | $1,033 | 37.4% |
| 92978 | Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | Facility | 2023 | 14 | 14 | $2,590 | $897.28 | 34.6% |
| 93571 | Ultrasound evaluation of heart blood vessel during diagnosis or treatment, initial vessel | Facility | 2023 | 13 | 13 | $3,822 | $668.72 | 17.5% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 32 | 39 | $12,870 | $6,535 | 50.8% |
| 93454 | Insertion of catheter for imaging of heart including imaging interpretation and supervision and injection | Facility | 2021 | 39 | 39 | $19,110 | $6,418 | 33.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 24 | 24 | $5,472 | $3,097 | 56.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 24 | 28 | $4,197 | $2,328 | 55.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 12 | 14 | $1,400 | $732.94 | 52.4% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 40 | 43 | $2,279 | $473.90 | 20.8% |
| 93454 | Insertion of catheter for imaging of heart blood vessels or grafts | Facility | 2020 | 43 | 43 | $21,070 | $6,711 | 31.8% |
| 92928 | Catheter insertion of stents in major coronary artery or branch, accessed through the skin | Facility | 2020 | 12 | 15 | $16,245 | $6,330 | 39.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 19 | 20 | $2,940 | $1,674 | 56.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 19 | 24 | $2,400 | $1,392 | 58.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 13 | 13 | $2,574 | $1,345 | 52.3% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2020 | 21 | 23 | $1,219 | $306.35 | 25.1% |
About Dr. Ankur Kalra, MD
Dr. Ankur Kalra, MD is a Cardiovascular Disease healthcare provider based in Syracuse, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/08/2010. The National Provider Identifier (NPI) number assigned to this provider is 1295042539.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ankur Kalra, MD has received a total of $26,848 in payments from pharmaceutical and medical device companies, with $3,651 received in 2024. These payments were reported across 138 transactions from 29 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($10,638).
As a Medicare-enrolled provider, Kalra has provided services to 883 Medicare beneficiaries, totaling 953 services with total Medicare billing of $87,069. Data is available for 3 years (2020–2023), covering 24 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Interventional Cardiology, Cardiovascular Disease
- Location Syracuse, NY
- Active Since 09/08/2010
- Last Updated 06/19/2025
- Taxonomy Code 207RC0000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1295042539
Products in Payments
- CAMZYOS (Drug) $4,014
- Resolute (Device) $3,233
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $1,724
- Veradius (Device) $1,552
- Aggrastat (tirofiban HCl) (Drug) $500.00
- Impella (Device) $455.35
- LifeVest (Device) $353.13
- Aortic and Mitral Tissue Stented (Device) $259.30
- AVVIGO Guidance System (Device) $216.58
- BRILINTA (Drug) $191.31
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $166.87
- COREVALVE EVOLUT R (Device) $165.94
- CoreValve Evolut (Device) $162.39
- GENERAL STENTS (Device) $142.22
- Contour 3D (Device) $118.12
- COMET (Device) $102.12
- XARELTO (Drug) $100.32
- ELIQUIS (Drug) $81.85
- FLOWTRIEVER CATHETER, S (Device) $78.14
- HawkOne (Device) $75.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Syracuse
Saverio Barbera, Md, MD
Cardiovascular Disease — Payments: $41,547
Cardiovascular Disease $41,547
Dr. Kiran Devaraj, M.d, M.D
Cardiovascular Disease — Payments: $36,432
Cardiovascular Disease $36,432
Dr. Nikhil Joshi, M.d, M.D
Cardiovascular Disease — Payments: $28,775
Cardiovascular Disease $28,775
Dr. Tristan Petrie, Md, MD
Cardiovascular Disease — Payments: $18,178
Cardiovascular Disease $18,178
Michael Gabris, Md Facc, MD FACC
Cardiovascular Disease — Payments: $11,834
Cardiovascular Disease $11,834
Dr. Cynthia Taub, Md, MD
Cardiovascular Disease — Payments: $10,954
Cardiovascular Disease $10,954